| Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis K Murata, H Yoshitomi, S Tanida, M Ishikawa, K Nishitani, H Ito, ... Arthritis research & therapy 12, 1-14, 2010 | 575 | 2010 |
| Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis K Murata, M Furu, H Yoshitomi, M Ishikawa, H Shibuya, M Hashimoto, ... PloS one 8 (7), e69118, 2013 | 224 | 2013 |
| MicroRNA‐451 down‐regulates neutrophil chemotaxis via p38 MAPK K Murata, H Yoshitomi, M Furu, M Ishikawa, H Shibuya, H Ito, S Matsuda Arthritis & rheumatology 66 (3), 549-559, 2014 | 142 | 2014 |
| Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery K Murata, T Yasuda, H Ito, M Yoshida, M Shimizu, T Nakamura Modern rheumatology 16 (1), 14-19, 2006 | 124 | 2006 |
| Inhibition of miR‐92a enhances fracture healing via promoting angiogenesis in a model of stabilized fracture in young mice K Murata, H Ito, H Yoshitomi, K Yamamoto, A Fukuda, J Yoshikawa, ... Journal of Bone and Mineral Research 29 (2), 316-326, 2014 | 117 | 2014 |
| MYC-dependent oxidative metabolism regulates osteoclastogenesis via nuclear receptor ERRα S Bae, MJ Lee, SH Mun, EG Giannopoulou, V Yong-Gonzalez, JR Cross, ... The Journal of clinical investigation 127 (7), 2555-2568, 2017 | 104 | 2017 |
| A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium S Kobayashi, K Murata, H Shibuya, M Morita, M Ishikawa, M Furu, H Ito, ... Arthritis & Rheumatism 65 (12), 3063-3072, 2013 | 101 | 2013 |
| MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing M Ishikawa, H Ito, T Kitaori, K Murata, H Shibuya, M Furu, H Yoshitomi, ... PLoS One 9 (8), e104954, 2014 | 86 | 2014 |
| Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis K Murata, C Fang, C Terao, EG Giannopoulou, YJ Lee, MJ Lee, SH Mun, ... Immunity 47 (1), 66-79. e5, 2017 | 84 | 2017 |
| Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments H Yoshitomi, S Kobayashi, A Miyagawa-Hayashino, A Okahata, K Doi, ... Nature communications 9 (1), 3762, 2018 | 77 | 2018 |
| Cutting edge: EZH2 promotes osteoclastogenesis by epigenetic silencing of the negative regulator IRF8 C Fang, YU Qiao, SH Mun, MJ Lee, K Murata, S Bae, B Zhao, ... The Journal of Immunology 196 (11), 4452-4456, 2016 | 75 | 2016 |
| IL-27-producing CD14+ cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration S Tanida, H Yoshitomi, M Ishikawa, T Kasahara, K Murata, H Shibuya, ... Cytokine 55 (2), 237-244, 2011 | 71 | 2011 |
| Laparoscopic anatomical liver resection using indocyanine green fluorescence imaging T Urade, H Sawa, Y Iwatani, T Abe, R Fujinaka, K Murata, Y Mii, M Man-i, ... Asian journal of surgery 43 (1), 362-368, 2020 | 69 | 2020 |
| Elderly onset of early rheumatoid arthritis is a risk factor for bone erosions, refractory to treatment: KURAMA cohort K Murata, H Ito, M Hashimoto, K Nishitani, K Murakami, M Tanaka, ... International Journal of Rheumatic Diseases 22 (6), 1084-1093, 2019 | 66 | 2019 |
| Indirect decompression via oblique lateral interbody fusion for severe degenerative lumbar spinal stenosis: a comparative study with direct decompression transforaminal … T Shimizu, S Fujibayashi, B Otsuki, K Murata, S Matsuda The Spine Journal 21 (6), 963-971, 2021 | 63 | 2021 |
| Lectin‐like oxidized low‐density lipoprotein receptor 1 signal is a potent biomarker and therapeutic target for human rheumatoid arthritis M Ishikawa, H Ito, M Akiyoshi, N Kume, H Yoshitomi, H Mitsuoka, ... Arthritis & Rheumatism 64 (4), 1024-1034, 2012 | 63 | 2012 |
| Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis-The ANSWER cohort study K Ebina, M Hashimoto, W Yamamoto, T Hirano, R Hara, M Katayama, ... PLoS One 14 (5), e0216624, 2019 | 62 | 2019 |
| Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study K Ebina, M Hashimoto, W Yamamoto, T Hirano, R Hara, M Katayama, ... Arthritis Research & Therapy 21, 1-10, 2019 | 57 | 2019 |
| Indirect decompression with lateral interbody fusion for severe degenerative lumbar spinal stenosis: minimum 1-year MRI follow-up T Shimizu, S Fujibayashi, B Otsuki, K Murata, S Matsuda Journal of Neurosurgery: Spine 33 (1), 27-34, 2020 | 43 | 2020 |
| Prevalence and predictive factors of difficult-to-treat rheumatoid arthritis: the KURAMA cohort R Watanabe, M Hashimoto, K Murata, K Murakami, M Tanaka, K Ohmura, ... Immunological Medicine 45 (1), 35-44, 2022 | 42 | 2022 |
